• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异喹胍羟化酶与帕金森病

Debrisoquine hydroxylase and Parkinson's disease.

作者信息

Kondo I, Kanazawa I

机构信息

Department of Human Ecology, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan.

出版信息

Adv Neurol. 1993;60:338-42.

PMID:8420147
Abstract

The relationship between the genotypes of Xba I and Bam H I restriction fragment length polymorphisms (RFLPs) at a gene for debrisoquine hydroxylase (CYP2D6) and phenotypes of the metabolic function of debrisoquine/sparteine, the EM and the PM in a healthy Japanese population was investigated. The genotypes of Xba I 11.5 kb and Xba I 44 kb-Bam H I 2.3 kb- were responsible for the Japanese PM. Genotype of Xba I RFLP at CYP2D6 locus was analyzed in 43 healthy individuals and 51 patients with IDP. The relative risk of IDP was 2.15 times more for individuals with the Xba I 44 kb allele compared to those without the allele (chi 2 = 4.149, d.f. = 1, p < 0.05) and it was 6.32 times greater for the Xba I 44 kb homozygotes than the Xba I 29 kb homozygotes (chi 2 = 4.935, d.f. = 1, p < 0.05). These data suggest that the PM for debrisoquine/sparteine hydroxylase might be one of the genetic factors making humans susceptible to IDP acquisition.

摘要

研究了健康日本人群中异喹胍羟化酶(CYP2D6)基因的Xba I和Bam H I限制性片段长度多态性(RFLP)基因型与异喹胍/司巴丁代谢功能表型、快代谢型(EM)和慢代谢型(PM)之间的关系。Xba I 11.5 kb和Xba I 44 kb - Bam H I 2.3 kb的基因型与日本人群中的慢代谢型有关。对43名健康个体和51名原发性免疫缺陷病(IDP)患者进行了CYP2D6位点Xba I RFLP基因型分析。与无Xba I 44 kb等位基因的个体相比,携带该等位基因的个体患IDP的相对风险高2.15倍(χ2 = 4.149,自由度 = 1,p < 0.05),Xba I 44 kb纯合子患IDP的风险比Xba I 29 kb纯合子高6.32倍(χ2 = 4.935,自由度 = 1,p < 0.05)。这些数据表明,异喹胍/司巴丁羟化酶的慢代谢型可能是使人类易患IDP的遗传因素之一。

相似文献

1
Debrisoquine hydroxylase and Parkinson's disease.异喹胍羟化酶与帕金森病
Adv Neurol. 1993;60:338-42.
2
Debrisoquine polymorphism: novel CYP2D6 gene Bam HI restriction fragment length polymorphism in the Ngawbé Guaymí Indian of Panama.异喹胍多态性:巴拿马恩加韦瓜伊米印第安人中新型CYP2D6基因Bam HI限制性片段长度多态性
Pharmacogenetics. 1991 Dec;1(3):136-42.
3
Identification of a novel CYP2D6 allele associated with poor metabolism of sparteine in a Japanese population.在日本人群中鉴定出一种与司巴丁代谢不良相关的新型CYP2D6等位基因。
Pharmacogenetics. 1991 Dec;1(3):161-4. doi: 10.1097/00008571-199112000-00006.
4
Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.对西非人群中CYP2D6基因突变及其对酶功能影响的分析。
Pharmacogenetics. 1999 Dec;9(6):715-23.
5
CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.多系统萎缩中细胞色素P450 2D6-异喹胍羟化酶基因多态性
Mov Disord. 1995 May;10(3):277-8. doi: 10.1002/mds.870100307.
6
Debrisoquine oxidation polymorphism: phenotypic consequences of a 3-base-pair deletion in exon 5 of the CYP2D6 gene.异喹胍氧化多态性:CYP2D6基因第5外显子3个碱基对缺失的表型后果。
Pharmacogenetics. 1993 Jun;3(3):123-30.
7
Debrisoquine hydroxylation genotype in familial forms of idiopathic Parkinson's disease.家族性特发性帕金森病中的异喹胍羟基化基因型
Adv Neurol. 1996;69:97-100.
8
Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population.异喹胍/鹰爪豆碱羟基化基因型与表型:欧洲人群中CYP2D6常见突变及等位基因分析
DNA Cell Biol. 1991 Oct;10(8):545-58. doi: 10.1089/dna.1991.10.545.
9
Association between the oxidative polymorphism and early onset of Parkinson's disease.氧化多态性与帕金森病早发之间的关联。
Clin Pharmacol Ther. 1995 Mar;57(3):291-8. doi: 10.1016/0009-9236(95)90154-X.
10
Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.在携带重复和多重复功能性CYP2D6等位基因的埃塞俄比亚人群中,异喹胍超快代谢者的频繁分布。
J Pharmacol Exp Ther. 1996 Jul;278(1):441-6.

引用本文的文献

1
Polymorphic cytochromes P450 and drugs used in psychiatry.多态性细胞色素P450与精神科用药
Cell Mol Neurobiol. 1999 Jun;19(3):325-54. doi: 10.1023/a:1006945715127.
2
Epidemiology of Parkinson's disease.帕金森病的流行病学
Neurol Clin. 1996 May;14(2):317-35. doi: 10.1016/S0733-8619(05)70259-0.